Lejeune A

References (2)

Title : Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice - Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
Author(s) : Roche C , Guerrot D , Harouki N , Duflot T , Besnier M , Remy-Jouet I , Renet S , Dumesnil A , Lejeune A , Morisseau C , Richard V , Bellien J
Ref : Prostaglandins Other Lipid Mediat , 120 :148 , 2015
Abstract : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
ESTHER : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
PubMedSearch : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
PubMedID: 26022136

Title : [Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years] - Michel_2001_Rev.Neurol.(Paris)_157_1365
Author(s) : Michel BF , Estadieu MC , Gueriot C , Berthezene P , Allain H , Bongrand MC , Bonnefoy B , Bourrin JC , Chaix L , Graa K , Lejeune A , Messana M , Pras P , Ribiere J , Rihet P , Timon-David P , Tintignac A , Vincent S , Verdier JM , Gastaut JL
Ref : Rev Neurol (Paris) , 157 :1365 , 2001
Abstract : Michel_2001_Rev.Neurol.(Paris)_157_1365
ESTHER : Michel_2001_Rev.Neurol.(Paris)_157_1365
PubMedSearch : Michel_2001_Rev.Neurol.(Paris)_157_1365
PubMedID: 11924005